FNDC5 and early-onset autosomal dominant Alzheimer disease: An intriguing “proof of concept” demonstrating irisin’s potential to fight neuroinflammation and its relevance to Alzheimer’s disease (AD) pathogenesis has been provided through studies investigating Aβ neurotoxicity in primary astrocyte and neuron cell cultures [110].